Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001628280-17-007466
Filing Date
2017-07-31
Accepted
2017-07-31 17:10:29
Documents
84
Period of Report
2017-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q akorn10q-06302017.htm 10-Q 1225510
2 EXHIBIT 31.1 exhibit311-06302017.htm EX-31.1 13547
3 EXHIBIT 31.2 exhibit312-06302017.htm EX-31.2 13555
4 EXHIBIT 32.1 exhibit321-06302017.htm EX-32.1 8782
5 EXHIBIT 32.2 exhibit322-06302017.htm EX-32.2 8798
  Complete submission text file 0001628280-17-007466.txt   7349711

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT akrx-20170630.xml EX-101.INS 1633558
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT akrx-20170630.xsd EX-101.SCH 54700
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT akrx-20170630_cal.xml EX-101.CAL 91833
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT akrx-20170630_def.xml EX-101.DEF 233285
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT akrx-20170630_lab.xml EX-101.LAB 734197
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT akrx-20170630_pre.xml EX-101.PRE 421244
Mailing Address 1925 W. FIELD COURT, SUITE 300 LAKE FOREST IL 60045
Business Address 1925 W. FIELD COURT, SUITE 300 LAKE FOREST IL 60045 847-279-6100
AKORN INC (Filer) CIK: 0000003116 (see all company filings)

EIN.: 720717400 | State of Incorp.: LA | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-32360 | Film No.: 17993729
SIC: 2834 Pharmaceutical Preparations